Long-Acting Injectable vs Oral Risperidone for Schizophrenia and Co-Occurring Alcohol Use Disorder

Alan I. Green, Mary F. Brunette, Ree Dawson, P.F. Buckley, Amy E. Wallace, Hisham Hafez, Marvin I. Herz, Meera Narasimhan, Douglas L. Noordsy, Christopher O’Keefe,

The Journal of Clinical Psychiatry · 2015 · 46 citations · 0 references

Abstract

ClinicalTrials.gov identifier: NCT00130923.